CMB International Securities  Equity Research  Company Update
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
China Technology Sector
Lily Yang PhD
Mkt Cap (RMB mn)
Avg 3 mths to (RMB mn)
52w HighLow (RMB)
Total Issued Shares (mn)
Source Bloomberg
Shareholding Structure
WX HUIZHI UNITED INV ENT
Source HKEx
Source Bloomberg
12-mth Price Performance
Source Bloomberg
Auditor BDO
unchanged despite short term
fluctuation  12 Jan 2022
Opportunity
Maxscend  7 Jan 2022
SZCOMP  (rebased)
BUY (Maintain)
(Previous TP
UpDownside
Maxscend announced FY21 preliminary results FY21 revenueNP grew 66%99%
YoY reaching RMB4636mn2139mn Top line slightly missed ourconsensus
expectations by 4%4% while bottom line beat ourconsensus est by 3%3%
Given recent weakness in Android market we lowered our forecasts for FY22E
TP adjusted to RMB415 Maintain BUY
 Mixed results for 2021 Maxscend FY21 revenue was RMB46bn up 661%
YoY 4Q21 revenue was RMB1153mn up 26% QoQ and 406%YoY  FY21
and 4Q21 top line missed ourconsensus expectations by 4%4% and
13%14% FY21 NP was RMB21bn up 99% YoY 4Q21 NP was RMB612mn
up 193% QoQ and 722%YoY FY21 and 4Q21 bottom line beat
ourconsensus est by 3%3% and 12%12% We believe the mixed results
profitability from newly released 5G module in 2021
 New products and filter production are in focus for 2022 For 2022 we
favorable product mix as module revenue has plenty growth opportunities in
top Android OEMs Given that the new manufacturing plant is currently under
pilot production we would watch closely on the ramp up status of its filter
business and its yield after production
 Maintain BUY with new TP of RMB4150 We lowered our FY22 revenueNP by
9%8% reflecting recent weak sales from Android OEMs We adjusted our TP to
RMB4150 based on same 50x FY22E PE Maxscend is currently trading at 1-SD
below historical PE We believe this valuation is attractive given 1) its leading
position in Chinas RFFE market 2) broad in-house designed product offerings
and 3) transition into fab-lite model to secure production capacity and full control
of its manufacturing process
lines and 3) further deteriorated marco environment Potential upside includes
MA opportunity
(YE 31 Dec)
Turnover (RMB mn)
YoY growth (%)
Gross margin (%)
Net profit (RMB mn)
YoY growth (%)
Diluted EPS (RMB)
Consensus EPS (RMB)
Net gearing (%)
Source Company data Bloomberg CMBIS estimates
Maxscend (300782 CH)
Mixed results for 2021 New products and filter
production are in focus for 2022
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
Figure 1 Quarterly results
Source Company data CMBIS
Figure 2 Annual results
Source Company data CMBIS
Figure 3 Earnings revision
Source Company data CMBIS
Figure 4 CMBI estimates vs consensus
Source Company data CMBIS estimates
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
Figure 5 PL forecast
Source Company data CMBIS estimates
Figure 6 12M forward PE
Source Company data CMBIS
Figure 7 12M forward PE band
Source Company data CMBIS
1-yr Forward PE
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
Source Company data CMBIS estimates
YE 31 Dec (RMB mn)
FY19A FY20A FY21E FY22E FY23E  YE 31 Dec (RMB mn)
FY19A FY20A FY21E FY22E FY23E
8265  Net profit
(719) (1317) (1989) (2803) (3774)  Depreciationamortization
4492  Change in working capital
(59)  Net cash from operating
(493)  Capex
Other operating incexp
(127)  Net cash from investing
Other non-oper exp
258  Dividend paid
Pre-tax profit
3988  Other
Net cash from financing
(2)  Net change in cash
Net profit to shareholders
3524  Cash beg
Exchange adj
YE 31 Dec (RMB mn)
FY19A FY20A FY21E FY22E FY23E  YE 31 Dec (RMB mn)
FY19A FY20A FY21E FY22E FY23E
7429  Revenue by segment
Cash  equivalents
3406  RFFE discrete
1528  RFFE module
1470  Other
925  Growth (%)
Non-current assets
3394  Gross profit
1188  Operating profit
26  Net profit
Other non-current assets
7712 10824  Profit  loss ratio (%)
829  Operating margin
0  Net profit margin
324  Balance sheet ratio
Other current liabilities
128  Net debttotal equity (%)
Current ratio  (x)
Non-current liabilities
85  Receivable turnover days
0  Inventory turnover days
Deferred tax liability
80  Payable turnover days
Other non-current
914  Profitability (%)
8010  Per share data (RMB)
9909  BPS
Total liabilities and
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
Disclosures  Disclaimers
Analyst Certification
The research analyst who is primary responsible for the content of this research report in whole or in part certifies that with respect to the securities
or issuer that the analyst covered in this report (1) all of the views expressed accurately reflect his or her personal views about the subject securities
in this report
Besides the analyst confirms that neither the analyst nor hisher associates (as defined in the code of conduct issued by The Hong Kong Securities
and Futures Commission) (1) have dealt in or traded in the stock(s) covered in this research report within 30 calendar days prior to the date of issue
of this report (2) will deal in or trade in the stock(s) covered in this research report 3 business days after the date of issue of this report (3) serve
covered in this report
 Stock with potential return of over 15% over next 12 months
 Stock with potential return of 15% to -10% over next 12 months
 Stock with potential loss of over 10% over next 12 months
 Stock is not rated by CMBIS
OUTPERFORM                     Industry expected to outperform the relevant broad market benchmark over next 12 months
MARKET-PERFORM             Industry expected to perform in-line with the relevant broad market benchmark over next 12 months
UNDERPERFORM                 Industry expected to underperform the relevant broad market benchmark over next 12 months
CMB International Securities Limited
Address 45F Champion Tower 3 Garden Road Hong Kong Tel (852) 3900 0888   Fax (852) 3900 0800
CMB International Securities Limited (CMBIS) is a wholly owned subsidiary of CMB International Capital Corporation Limited (a wholly owned subsidiary
of China Merchants Bank)
Important Disclosures
There are risks involved in transacting in any securities  The information contained in this report may not be suitable for the purposes of all investors  CMBIS does not
provide individually tailored investment advice This report has been prepared without regard to the individual investment objectives financial position or special
requirements  Past performance has no indication of future performance and actual events may differ materially from that which is contained in the report  The value
of and returns from any investments are uncertain and are not guaranteed and may fluctuate as a result of their dependence on the performance of underlying assets
consult with a professional financial advisor in order to make their own investment decisions
This report or any information contained herein have been prepared by the CMBIS solely for the purpose of supplying information to the clients of CMBIS or its affiliate(s)
to whom it is distributed  This report is not and should not be construed as an offer or solicitation to buy or sell any security or any interest in securities or enter into any
transaction  Neither CMBIS nor any of its affiliates shareholders agents consultants directors officers or employees shall be liable for any loss damage or expense
whatsoever whether direct or consequential incurred in relying on the information contained in this report  Anyone making use of the information contained in this report
does so entirely at their own risk
The information and contents contained in this report are based on the analyses and interpretations of information believed to be publicly available and reliable CMBIS
and forecasts on an AS IS basis  The information and contents are subject to change without notice CMBIS may issue other publications having information and or
report As a result recipients should be aware that CMBIS may have a conflict of interest that could affect the objectivity of this report and CMBIS will not assume any
responsibility in respect thereof This report is for the use of intended recipients only and this publication may not be reproduced reprinted sold redistributed or published
in whole or in part for any purpose without prior written consent of CMBIS
For recipients of this document in the United Kingdom
This report has been provided only to persons (I)falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended
from time to time)(The Order) or (II) are persons falling within Article 49(2) (a) to (d) (High Net Worth Companies Unincorporated Associations etc) of the Order and
may not be provided to any other person without the prior written consent of CMBIS
For recipients of this document in the United States
CMBIS is not a registered broker-dealer in the United States  As a result CMBIS is not subject to US rules regarding the preparation of research reports and the
independence of research analysts  The research analyst who is primary responsible for the content of this research report is not registered or qualified as a research
analyst with the Financial Industry Regulatory Authority (FINRA)  The analyst is not subject to applicable restrictions under FINRA Rules intended to ensure that the
analyst is not affected by potential conflicts of interest that could bear upon the reliability of the research report This report is intended for distribution in the United States
solely to major US institutional investors as defined in Rule 15a-6 under the US Securities Exchange Act of 1934 as amended and may not be furnished to any other
person in the United States Each major US institutional investor that receives a copy of this report by its acceptance hereof represents and agrees that it shall not
distribute or provide this report to any other person Any US recipient of this report wishing to effect any transaction to buy or sell securities based on the information
provided in this report should do so only through a US-registered broker-dealer
For recipients of this document in Singapore
This report is distributed in Singapore by CMBI (Singapore) Pte Limited (CMBISG) (Company Regn No 201731928D) an Exempt Financial Adviser as defined in the
Financial Advisers Act (Cap 110) of Singapore and regulated by the Monetary Authority of Singapore CMBISG may distribute reports produced by its respective foreign
entities affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations Where the report is distributed
in Singapore to a person who is not an Accredited Investor Expert Investor or an Institutional Investor as defined in the Securities and Futures Act (Cap 289) of
Singapore CMBISG accepts legal responsibility for the contents of the report to such persons only to the extent required by law Singapore recipients should contact
CMBISG at 65 6350 4400 for matters arising from or in connection with the report